February 20, 2019
“A new AI technology dubbed DeepGestalt is able to identify several genetic disorders by scanning a photograph of a patient’s face. FDNA, an artificial intelligence and precision medicine company responsible for the development, claims that the AI program is much better than physicians at identifying diseases such as Angelman Syndrome or Noonan Syndrome. Having been trained with 17,000 images of patients with nearly 200 genetic disorders, DeepGestalt was able to correctly diagnose Noonan syndrome 64% of the time as opposed to clinicians (20%) using facial characteristics the researchers and doctors were not able to pinpoint.”
The PM360 article describes how Face2Gene uses artificial intelligence to analyze facial features and accurately expedite the diagnosis of genetic disorders, enhancing early detection and personalized treatment plans. DeepGestalt analyzes facial features against a comprehensive database, accurately identifying potential disorders even if they’re ultra-rare or not initially included in the training data. This technology exemplifies the growing integration of AI in healthcare, offering significant improvements in diagnostic precision and patient care. The article highlights the impact of such innovations on the industry, transforming traditional medical practices and optimizing clinical workflows.
